![2020 07 16 17 14 3089 3 M Lab 400](https://img.labpulse.com/files/base/smg/all/image/2020/07/lp.2020_07_16_17_14_3089_3M_lab_400.png?auto=format%2Ccompress&q=70&w=400)
3M and the Massachusetts Institute of Technology (MIT) are working together to develop a rapid point-of-care diagnostic for COVID-19 disease.
The project is being conducted under the auspices of the U.S. National Institutes of Health's (NIH) Rapid Acceleration of Diagnostics Tech (RADx Tech) program, a COVID-19 diagnostics initiative, and has received $500,000 in funding, 3M said. The company is working with a research team led by Hadley Sikes, PhD, of the MIT Department of Chemical Engineering.
![3M COVID-19 test team at the pilot lab facility at 3M's global headquarters in St. Paul, Minnesota. Image courtesy of Business Wire.](https://img.labpulse.com/files/base/smg/all/image/2020/07/lp.2020_07_16_17_14_3089_3M_lab_400.png?auto=format%2Ccompress&fit=max&q=70&w=400)
The test would identify viral antigens and deliver results in minutes, without the need for samples to be sent to labs.